CCEL vs NIVF: stock comparison and AI forecast
Cryo Cell International Inc (CCEL) and Newgenivf Group Ltd (NIVF) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CCEL Cryo Cell International Inc
- Price
- $4.95 +38.3% · 6M
- Market Cap
- $40M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NIVF Newgenivf Group Ltd
- Market Cap
- $5M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CCEL is 8.5 times larger than NIVF by market capitalization ($40M against $5M).
- CCEL yields 8.10% in dividends; NIVF pays none.
- Both companies share the SEC industry classification Services-Misc Health & Allied Services, NEC.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CCEL | NIVF |
|---|---|---|
| Market Cap | $40M | $5M |
| P/B Ratio | – | 0.18x |
| Dividend Yield | 8.10% | – |
| EPS | $-0.23 | – |
| Book Value/Share | – | $2.75 |
| Revenue/Share | $3.86 | – |
| FCF/Share | $0.58 | – |
Profitability & Margins
| Metric | CCEL | NIVF |
|---|---|---|
| ROA | -3.1% | – |
| ROIC | 0.4% | – |
| Gross Margin | 78.5% | – |
| Operating Margin | 0.6% | – |
| Net Margin | -6.2% | – |
| EBT Margin | -6.1% | – |
| Tax Rate | -1.9% | – |
Financial Health
| Metric | CCEL | NIVF |
|---|---|---|
| Current Ratio | 0.86x | – |
| Quick Ratio | 0.82x | – |
| D/E Ratio | – | 0.25x |
| Financial Leverage | – | 1.23x |
| Interest Coverage | 5.0x | -17.4x |
| Working Capital | -$2M | – |
Cash Flow
| Metric | CCEL | NIVF |
|---|---|---|
| Operating Cash Flow | $5M | – |
| Free Cash Flow | $5M | – |
| Capital Spending | -$270K | – |
| OCF Growth YoY | -22.6% | – |
| FCF Growth YoY | -24.8% | – |
| FCF/Sales | 14.9% | – |
| CapEx/Sales | 0.9% | – |
Operational Efficiency
| Metric | CCEL | NIVF |
|---|---|---|
| Asset Turnover | 0.50x | – |
| Receivables Turnover | 4.5x | – |
| Inventory Turnover | 12.5x | – |
| Fixed Assets Turnover | 1.5x | – |
| Days Sales Outstanding | 80 days | – |
| Days Inventory | 29 days | – |
| Payables Period | 132 days | – |
| Cash Conversion Cycle | -23 days | – |
Income Statement
| Metric | CCEL | NIVF |
|---|---|---|
| Total Revenue | $31M | – |
| Operating Income | $190K | – |
| Net Income | -$2M | – |
| R&D Expense | $300K | – |
| SG&A Expense | $19M | – |
| Cost of Goods Sold | $7M | – |
Dividend & Shareholder Information
| Metric | CCEL | NIVF |
|---|---|---|
| Dividends Per Share | $0.40 | – |
| Shares Outstanding | 8M | 10M |
| EPS Growth | -2400.0% | – |
CCEL vs NIVF: stock comparison and AI forecast
Which is bigger, CCEL or NIVF?
CCEL is 8.5 times larger than NIVF by market capitalization ($40M against $5M).
Which one does Intratio's AI model rank higher, CCEL or NIVF?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.